Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell TransplantationYago Nieto, Roy B. Jones, Peggy Russell et al.|Journal of Clinical Oncology|2000Cited by 62
Prognostic Analysis of Early Lymphocyte Recovery in Patients with Advanced Breast Cancer Receiving High-Dose Chemotherapy with an Autologous Hematopoietic Progenitor Cell TransplantYago Nieto, Roy B. Jones, Elizabeth J. Shpall et al.|Clinical Cancer Research|2004Cited by 47
Long-Term Analysis and Prospective Validation of a Prognostic Model for Patients with High-Risk Primary Breast Cancer Receiving High-Dose ChemotherapyYago Nieto, Roy B. Jones, James R. Murphy et al.|Clinical Cancer Research|2004Cited by 20